Kisqali 200 MG daily dose UU 21S
Ended Awarded
- Contract number
- SPE2DB25FBCY4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,812
Award facts
- Contract value 100% obligated
- $41,812.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $41,812.32 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Kisqali 200 mg daily dose units in quantities of 21. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's substantial IDC with DLA functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Kisqali, a brand-name oncology medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and broader federal healthcare systems through a flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DB25FBCY4?
SPE2DB25FBCY4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FBCY4 worth?
The government has obligated $41,812 on SPE2DB25FBCY4.
Is contract SPE2DB25FBCY4 an order under another contract?
Yes. SPE2DB25FBCY4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCY4 competed?
The extent of competition for SPE2DB25FBCY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award